Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2012 | 08-2012 | 06-2012 | 05-2012 | 03-2012 | |
| Operating Expenses | 1,240 | 0 | 0 | 0 | 1,003 |
| Operating Income | -1,240 | N/A | N/A | N/A | -1,003 |
| Other Income | 0 | 0 | 0 | 0 | -7 |
| Pre-tax Income | -1,240 | 0 | 0 | 0 | -1,010 |
| Net Income Continuous | -1,291 | N/A | 1,014 | N/A | -1,025 |
| Net Income | $-1,291 | $N/A | $1,014 | $N/A | $-1,025 |
| EPS Basic Total Ops | -5.40 | N/A | 9.00 | N/A | -9.00 |
| EPS Basic Continuous Ops | -5.50 | N/A | 9.01 | N/A | -8.72 |
| EPS Diluted Total Ops | -5.40 | N/A | 9.00 | N/A | -9.00 |
| EPS Diluted Continuous Ops | -5.50 | N/A | 9.01 | N/A | -8.72 |
| EBITDA(a) | $-1,270 | $N/A | $10 | $N/A | $-973 |